Transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells

Abstract Background Renal erythropoietin (EPO)-producing (REP) cells produce EPO through hypoxia-inducible factor (HIF) 2α-activated gene transcription. Insufficient EPO production leads to anemia in patients with chronic kidney disease. Although recombinant EPO is effective to improve anemia, no re...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hong-Mou Shih, Szu-Yu Pan, Chih-Jen Wu, Yu-Hsiang Chou, Chun-Yuan Chen, Fan-Chi Chang, Yi-Ting Chen, Wen-Chih Chiang, Hsing-Chen Tsai, Yung-Ming Chen, Shuei-Liong Lin
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
R
Acceso en línea:https://doaj.org/article/4cecab6670294871beec1077d0bd73b3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4cecab6670294871beec1077d0bd73b3
record_format dspace
spelling oai:doaj.org-article:4cecab6670294871beec1077d0bd73b32021-11-08T10:45:19ZTransforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells10.1186/s12929-021-00770-21423-0127https://doaj.org/article/4cecab6670294871beec1077d0bd73b32021-11-01T00:00:00Zhttps://doi.org/10.1186/s12929-021-00770-2https://doaj.org/toc/1423-0127Abstract Background Renal erythropoietin (EPO)-producing (REP) cells produce EPO through hypoxia-inducible factor (HIF) 2α-activated gene transcription. Insufficient EPO production leads to anemia in patients with chronic kidney disease. Although recombinant EPO is effective to improve anemia, no reliable REP cell lines limit further progress of research and development of novel treatment. Methods We screened Epo mRNA expression in mouse fibroblast cell lines. Small interfering RNA specific for HIF1α or HIF2α was transfected to study Epo expression in C3H10T1/2 cells. The effect of transforming growth factor-β1 (TGF-β1) on HIF-EPO axis was studied in C3H10T1/2 cells and mice. Results Similar to mouse REP pericytes, C3H10T1/2 cells differentiated to α-smooth muscle actin+ myofibroblasts after exposure to TGF-β1. Specific HIF knockdown demonstrated the role of HIF2α in hypoxia-induced Epo expression. Sustained TGF-β1 exposure increased neither DNA methyltransferase nor methylation of Epas1 and Epo genes. However, TGF-β1 repressed HIF2α-encoding Epas1 promptly through activating activin receptor-like kinase-5 (ALK5), thereby decreasing Epo induction by hypoxia and prolyl hydroxylase domain inhibitor roxadustat. In mice with pro-fibrotic injury induced by ureteral obstruction, upregulation of Tgfb1 was accompanied with downregulation of Epas1 and Epo in injured kidneys and myofibroblasts, which were reversed by ALK5 inhibitor SB431542. Conclusion C3H10T1/2 cells possessed the property of HIF2α-dependent Epo expression in REP pericytes. TGF-β1 induced not only the transition to myofibroblasts but also a repressive effect on Epas1-Epo axis in C3H10T1/2 cells. The repressive effect of TGF-β1 on Epas1-Epo axis was confirmed in REP pericytes in vivo. Inhibition of TGF-β1-ALK5 signaling might provide a novel treatment to rescue EPO expression in REP pericytes of injured kidney.Hong-Mou ShihSzu-Yu PanChih-Jen WuYu-Hsiang ChouChun-Yuan ChenFan-Chi ChangYi-Ting ChenWen-Chih ChiangHsing-Chen TsaiYung-Ming ChenShuei-Liong LinBMCarticleErythropoietinHypoxia-inducible factor 2αPericyteTransforming growth factor-β1MedicineRENJournal of Biomedical Science, Vol 28, Iss 1, Pp 1-17 (2021)
institution DOAJ
collection DOAJ
language EN
topic Erythropoietin
Hypoxia-inducible factor 2α
Pericyte
Transforming growth factor-β1
Medicine
R
spellingShingle Erythropoietin
Hypoxia-inducible factor 2α
Pericyte
Transforming growth factor-β1
Medicine
R
Hong-Mou Shih
Szu-Yu Pan
Chih-Jen Wu
Yu-Hsiang Chou
Chun-Yuan Chen
Fan-Chi Chang
Yi-Ting Chen
Wen-Chih Chiang
Hsing-Chen Tsai
Yung-Ming Chen
Shuei-Liong Lin
Transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells
description Abstract Background Renal erythropoietin (EPO)-producing (REP) cells produce EPO through hypoxia-inducible factor (HIF) 2α-activated gene transcription. Insufficient EPO production leads to anemia in patients with chronic kidney disease. Although recombinant EPO is effective to improve anemia, no reliable REP cell lines limit further progress of research and development of novel treatment. Methods We screened Epo mRNA expression in mouse fibroblast cell lines. Small interfering RNA specific for HIF1α or HIF2α was transfected to study Epo expression in C3H10T1/2 cells. The effect of transforming growth factor-β1 (TGF-β1) on HIF-EPO axis was studied in C3H10T1/2 cells and mice. Results Similar to mouse REP pericytes, C3H10T1/2 cells differentiated to α-smooth muscle actin+ myofibroblasts after exposure to TGF-β1. Specific HIF knockdown demonstrated the role of HIF2α in hypoxia-induced Epo expression. Sustained TGF-β1 exposure increased neither DNA methyltransferase nor methylation of Epas1 and Epo genes. However, TGF-β1 repressed HIF2α-encoding Epas1 promptly through activating activin receptor-like kinase-5 (ALK5), thereby decreasing Epo induction by hypoxia and prolyl hydroxylase domain inhibitor roxadustat. In mice with pro-fibrotic injury induced by ureteral obstruction, upregulation of Tgfb1 was accompanied with downregulation of Epas1 and Epo in injured kidneys and myofibroblasts, which were reversed by ALK5 inhibitor SB431542. Conclusion C3H10T1/2 cells possessed the property of HIF2α-dependent Epo expression in REP pericytes. TGF-β1 induced not only the transition to myofibroblasts but also a repressive effect on Epas1-Epo axis in C3H10T1/2 cells. The repressive effect of TGF-β1 on Epas1-Epo axis was confirmed in REP pericytes in vivo. Inhibition of TGF-β1-ALK5 signaling might provide a novel treatment to rescue EPO expression in REP pericytes of injured kidney.
format article
author Hong-Mou Shih
Szu-Yu Pan
Chih-Jen Wu
Yu-Hsiang Chou
Chun-Yuan Chen
Fan-Chi Chang
Yi-Ting Chen
Wen-Chih Chiang
Hsing-Chen Tsai
Yung-Ming Chen
Shuei-Liong Lin
author_facet Hong-Mou Shih
Szu-Yu Pan
Chih-Jen Wu
Yu-Hsiang Chou
Chun-Yuan Chen
Fan-Chi Chang
Yi-Ting Chen
Wen-Chih Chiang
Hsing-Chen Tsai
Yung-Ming Chen
Shuei-Liong Lin
author_sort Hong-Mou Shih
title Transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells
title_short Transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells
title_full Transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells
title_fullStr Transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells
title_full_unstemmed Transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells
title_sort transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells
publisher BMC
publishDate 2021
url https://doaj.org/article/4cecab6670294871beec1077d0bd73b3
work_keys_str_mv AT hongmoushih transforminggrowthfactorb1decreaseserythropoietinproductionthroughrepressinghypoxiainduciblefactor2ainerythropoietinproducingcells
AT szuyupan transforminggrowthfactorb1decreaseserythropoietinproductionthroughrepressinghypoxiainduciblefactor2ainerythropoietinproducingcells
AT chihjenwu transforminggrowthfactorb1decreaseserythropoietinproductionthroughrepressinghypoxiainduciblefactor2ainerythropoietinproducingcells
AT yuhsiangchou transforminggrowthfactorb1decreaseserythropoietinproductionthroughrepressinghypoxiainduciblefactor2ainerythropoietinproducingcells
AT chunyuanchen transforminggrowthfactorb1decreaseserythropoietinproductionthroughrepressinghypoxiainduciblefactor2ainerythropoietinproducingcells
AT fanchichang transforminggrowthfactorb1decreaseserythropoietinproductionthroughrepressinghypoxiainduciblefactor2ainerythropoietinproducingcells
AT yitingchen transforminggrowthfactorb1decreaseserythropoietinproductionthroughrepressinghypoxiainduciblefactor2ainerythropoietinproducingcells
AT wenchihchiang transforminggrowthfactorb1decreaseserythropoietinproductionthroughrepressinghypoxiainduciblefactor2ainerythropoietinproducingcells
AT hsingchentsai transforminggrowthfactorb1decreaseserythropoietinproductionthroughrepressinghypoxiainduciblefactor2ainerythropoietinproducingcells
AT yungmingchen transforminggrowthfactorb1decreaseserythropoietinproductionthroughrepressinghypoxiainduciblefactor2ainerythropoietinproducingcells
AT shueilionglin transforminggrowthfactorb1decreaseserythropoietinproductionthroughrepressinghypoxiainduciblefactor2ainerythropoietinproducingcells
_version_ 1718442614956490752